Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19fm0108006, JP19fk0108031, JP19fk0108058, JP19fk0108056, JP18am001007, JP19fk0108066)
Ministry of Education, Culture, Sports, Science and Technology (16H06429, 16K21723, 16H06434)
Received: 29 April 2019
Accepted: 11 October 2019
First Online: 25 November 2019
: M.Imai, Y.S.-T., K.I.-H., M.Kiso, J.M., A.Y., K.Takada, M.Ito, N.N., K.Takahashi, T.J.S.L., J.D., Z.K., D.K., H.V.B., A.T., H.Hagiwara, N.I., H.K., T.N., N.W., M.Koga, E.A., D.J. and H.Hasegawa have no competing interests. M.Y. has received a speaker’s honoraria from Daiichi Sankyo. Y.K. has received a speaker’s honoraria from Toyama Chemical and Astellas, grant support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Shionogi & Co and Kyoritsu Seiyaku, and is a founder of FluGen.